In late March, we decided to cancel all committee meetings and not publish any draft or final guidelines until further notice (except for guidance that is therapeutically critical or focused on COVID-19-related issues – see the link in the yellow banner at the top of the page). We are continuing with work where we can, however the consultation for this guideline will be delayed. We will provide further information on the revised timeline as soon as possible.
 
Status Schedule affected by COVID-19
Developed As CG

Project Team

Developer National Guideline Centre

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
11 May 2021 Committee list updated
12 February 2021 - 30 March 2021 Draft guidance consultation
11 February 2021 Stakeholder list updated
01 February 2021 Pre-consultation documents released
15 May 2020 Schedule affected by COVID-19. In late March, we decided to cancel all committee meetings and not publish any draft or final guidelines until further notice (except for guidance that is therapeutically critical or focused on COVID-19-related issues – see the link in the yellow banner at the top of the page). We are continuing with work where we can, however the consultation for this guideline will be delayed. We will provide further information on the revised timeline as soon as possible.
16 January 2019 Committee meeting
19 December 2018 Declaration of interests
30 October 2018 Scope published
22 August 2018 - 20 September 2018 Draft scope consultation
13 August 2018 Scoping workshop
04 January 2018 Recruitment for GC chair began on 4 January and will close on 17 January 2018. For further information see: https://www.nice.org.uk/get-involved/join-a-committee/chair-subarachnoid-haemorrhage-guideline-committee

For further information on the guideline development process, please read how we develop NICE guidelines